Before
This page announces the exceptional approval of a COVID-19 treatment drug by Japan's Ministry of Health, Labour and Welfare on February 10, 2022. Pfizer's "Paxlovid Pack" (generic name: nirmatrelvir and ritonavir) received special approval under Article 14-3 of the Pharmaceutical Affairs Law. The application was submitted on January 14, 2022, for treating SARS-CoV-2 infections. Additional details are provided in the attached press release and statement from the Minister of Health, Labour and Welfare.
